Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and “BRCA-Like” Status, in Both Blood and Tumour DNA

Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response

(2016) Nicolas De Picciotto et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer

(2015) X. Zhu et al.   BREAST CANCER RESEARCH AND TREATMENT

Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes

(2015) Balázs Győrffy et al.   INTERNATIONAL JOURNAL OF CANCER

BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential

(2015) Tesa M. Severson et al.   Molecular Oncology

Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies

(2015) Li Zhang et al.   Scientific Reports

Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk

(2015) Yoon Hee Cho et al.   Journal of Cancer

Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

(2014) M. D. Burstein et al.   CLINICAL CANCER RESEARCH

TumourMLH1promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC)

(2014) K Newton et al.   JOURNAL OF MEDICAL GENETICS

BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC

(2013) T. Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

Platform comparisons for identification of breast cancers with a BRCA-like copy number profile

(2013) Philip C. Schouten et al.   BREAST CANCER RESEARCH AND TREATMENT

Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis

(2013) Liang Wu et al.   BREAST CANCER RESEARCH AND TREATMENT

Pyrosequencing analysis of BRCA1 methylation level in breast cancer cells

(2013) Fengfeng Cai et al.   TUMOR BIOLOGY

Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer

(2012) Seth Rummel et al.   BREAST CANCER RESEARCH AND TREATMENT

Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk

(2012) K. Brennan et al.   CANCER RESEARCH

Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls

(2012) Susan R. Sturgeon et al.   Epigenetics

BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression

(2012) Amanjit Bal et al.   VIRCHOWS ARCHIV

Morphological predictors of BRCA1 germline mutations in young women with breast cancer

(2011) M C Southey et al.   BRITISH JOURNAL OF CANCER

CpG island hypermethylation ofBRCA1and loss of pRb as co-occurring events in basal/triple-negative breast cancer

(2011) Olafur Andri Stefansson et al.   Epigenetics

DNA methylation in white blood cells

(2011) Mary Beth Terry et al.   Epigenetics

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer

(2011) D. G. Evans et al.   JOURNAL OF MEDICAL GENETICS

Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese

(2011) Da Pang et al.   MEDICAL ONCOLOGY

Triple-Negative Breast Cancer: An Unmet Medical Need

(2011) C. A. Hudis et al.   ONCOLOGIST

Molecular Stratification of Triple-Negative Breast Cancers

(2011) C. M. Perou   ONCOLOGIST

Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers

(2011) J.L. Hopper et al.   PATHOLOGY

Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer

(2010) E. M. Wong et al.   Cancer Prevention Research

BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)- Ribose Polymerase Inhibitors

(2010) Jurgen Veeck et al.   JOURNAL OF CLINICAL ONCOLOGY

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

(2010) Sunil Badve et al.   MODERN PATHOLOGY

High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

(2009) E. Manie et al.   CANCER RESEARCH

Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer

(2009) Aye Aye Thike et al.   MODERN PATHOLOGY

BRCA1 promoter methylation is associated with increased mortality among women with breast cancer

(2008) Xinran Xu et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast cancer special types: why bother?

(2008) JS Reis-Filho et al.   JOURNAL OF PATHOLOGY